UnitedHealth remains in fine financial shape. As of December 2024, the company owed $77 billion in debt (held at the parent level), or gross debt/EBITDA of around 2 times. The parent company typically ...

Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

Attorney General Andrea Campbell and a few of her peers sued CVS on Wednesday, alleging the pharmacy giant for years failed to provide Medicaid members with access to ...

It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are ...

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since ...

Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...

It is alleged that CVS falsely overbilled state Medicaid programs for prescription drugs dispensed at its retail pharmacies.

Application error: a client-side exception has occurred (see the browser console for more information).

Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...